Home > Boards > US Listed > Medical - Drugs > Dr. Reddy's Laboratories Limited (RDY)

$RDY http://thewellesleysnews.com/2017/09/19/stocks-that-may-be-worth-big-bets-dr-reddys-laboratorie

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
SpotOnTrade Member Profile
Member Level 
Followed By 790
Posts 127,692
Boards Moderated 8
Alias Born 08/13/10
160x600 placeholder
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 3/1/2021 10:18:54 AM
Dr. Reddy's requested by India to give more data for Sputnik V approval Seeking Alpha - 2/25/2021 11:07:03 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/22/2021 7:14:42 AM
Dr. Reddy's launches generic Prevacid SoluTab tablets in U.S. Seeking Alpha - 2/22/2021 3:06:02 AM
Dr. Reddy's Laboratories Announces the Launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market Business Wire - 2/22/2021 1:13:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/19/2021 8:25:51 AM
Dr. Reddy's seeks emergency use nod for Sputnik V in India Seeking Alpha - 2/19/2021 6:10:52 AM
Dr. Reddy's Initiates Process for Emergency Use Authorization of Sputnik V Business Wire - 2/19/2021 5:45:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/18/2021 8:09:04 AM
Dr. Reddy's launches generic Prolixin tablets in U.S. Seeking Alpha - 2/18/2021 3:36:49 AM
Dr. Reddy's Laboratories announces the launch of Fluphenazine Hydrochloride Tablets, USP in the U.S. Market Business Wire - 2/18/2021 1:50:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/17/2021 6:31:19 AM
Dr. Reddy's launches generic capecitabine tablets in U.S. Seeking Alpha - 2/17/2021 5:21:18 AM
Dr. Reddy's Laboratories Announces the Launch of Capecitabine Tablets, USP in the U.S. Market Business Wire - 2/17/2021 5:11:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/3/2021 11:32:50 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 2/2/2021 7:16:34 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/2/2021 7:06:51 AM
Dr. Reddy's Laboratories Announces the Launch of Vigabatrin Tablets, USP in the U.S. Market Business Wire - 2/2/2021 4:20:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 1/29/2021 8:10:04 AM
Dr. Reddy’s Q3 & 9M FY21 Financial Results Business Wire - 1/29/2021 4:37:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 1/27/2021 9:08:09 AM
Dr. Reddy’s and GRA announces Avigan Pivotal Studies Update Business Wire - 1/27/2021 5:02:00 AM
Dr. Reddy’s Receives Approval to Conduct Phase 3 Clinical Trial for Sputnik V Vaccine in India Business Wire - 1/15/2021 12:33:00 PM
Sputnik V meets the primary endpoint of safety in the Phase 2 Clinical Trial in India Business Wire - 1/11/2021 10:25:00 AM
Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) Edgar (US Regulatory) - 1/11/2021 8:48:27 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences